You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study

Article metrics

Article menu

Download PDFPDF

Systemic sclerosis
Original research
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study

 

Online download statistics by month:

Online download statistics by month: February 2023 to September 2024

AbstractFullPdf
Feb 2023244246108
Mar 2023221216114
Apr 202313412572
May 2023818161
Jun 2023797638
Jul 2023717030
Aug 2023716329
Sep 2023564939
Oct 2023575349
Nov 2023474230
Dec 2023434533
Jan 2024484641
Feb 2024403629
Mar 2024635483
Apr 2024686242
May 2024596037
Jun 2024605730
Jul 2024807431
Aug 2024666133
Sep 2024483922
Total16361555951